Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
暂无分享,去创建一个
R. Advani | R. Bouabdallah | H. Tilly | T. Illidge | R. Ramchandren | C. Moskowitz | T. Trippett | A. Gopal | A. Shustov | L. Grove | A. Gibb | Robert Chen